By Stephen Nakrosis

Masimo on Friday said the Masimo W1 medical watch received 510(k) clearance from the U.S. Food and Drug Administration for over-the-counter and prescription use

The Masimo W1 is "the first FDA-cleared watch to provide continuous real-time oxygen saturation and pulse rate for OTC and Rx use," the company said.

Data from the integrated Masimo MW-1 module is displayed in real-time on the Masimo W1 watch touchscreen, the company said.

Section 510(k) of the Food, Drug and Cosmetic Act requires manufacturers to give the FDA 90 days advance notice before they can market a medical device.

Write to Stephen Nakrosis at stephen.nakrosis@wsj.com

(END) Dow Jones Newswires

November 17, 2023 16:58 ET (21:58 GMT)

Copyright (c) 2023 Dow Jones & Company, Inc.
Grafico Azioni Masimo (NASDAQ:MASI)
Storico
Da Apr 2024 a Mag 2024 Clicca qui per i Grafici di Masimo
Grafico Azioni Masimo (NASDAQ:MASI)
Storico
Da Mag 2023 a Mag 2024 Clicca qui per i Grafici di Masimo